Ameriprise’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-87,464
Closed -$1.33M 4037
2022
Q1
$1.33M Hold
87,464
﹤0.01% 3083
2021
Q4
$1.34M Sell
87,464
-975,235
-92% -$12.8M ﹤0.01% 3120
2021
Q3
$9.26M Buy
1,062,699
+663,980
+167% +$6.05M ﹤0.01% 1913
2021
Q2
$4.07M Buy
398,719
+47,068
+13% +$497K ﹤0.01% 2589
2021
Q1
$4.2M Buy
351,651
+252,773
+256% +$2.87M ﹤0.01% 2494
2020
Q4
$899K Sell
98,878
-31,673
-24% -$245K ﹤0.01% 3133
2020
Q3
$794K Sell
130,551
-23,331
-15% -$178K ﹤0.01% 3069
2020
Q2
$1.37M Buy
153,882
+129,118
+521% +$1.11M ﹤0.01% 2778
2020
Q1
$180K Hold
24,764
﹤0.01% 3456
2019
Q4
$218K Buy
24,764
+3,764
+18% +$28.2K ﹤0.01% 3558
2019
Q3
$128K Sell
21,000
-6,650
-24% -$37.4K ﹤0.01% 3615
2019
Q2
$115K Sell
27,650
-420
-1% -$2.21K ﹤0.01% 3652
2019
Q1
$176K Hold
28,070
﹤0.01% 3571
2018
Q4
$182K Hold
28,070
﹤0.01% 3458
2018
Q3
$233K Hold
28,070
﹤0.01% 3507
2018
Q2
$175K Buy
+28,070
New +$178K ﹤0.01% 3512
2018
Q1
Sell
-21,761
Closed -$143K 3724
2017
Q4
$143K Sell
21,761
-1,890
-8% -$11.5K ﹤0.01% 3529
2017
Q3
$131K Buy
23,651
+3,050
+15% +$20.6K ﹤0.01% 3581
2017
Q2
$159K Buy
+20,601
New +$174K ﹤0.01% 3608
2016
Q4
Sell
-93,959
Closed -$1.53M 3972
2016
Q3
$1.53M Buy
+93,959
New +$1.32M ﹤0.01% 2711
2016
Q2
Sell
-370,650
Closed -$5.2M 3866
2016
Q1
$5.2M Sell
370,650
-79,676
-18% -$825K ﹤0.01% 1914
2015
Q4
$4.89M Buy
450,326
+265,156
+143% +$2.4M ﹤0.01% 2034
2015
Q3
$1.26M Buy
185,170
+30,645
+20% +$237K ﹤0.01% 2874
2015
Q2
$1.41M Buy
+154,525
New +$1.17M ﹤0.01% 2954
2014
Q3
Sell
-20
Closed 5927
2014
Q2
$0 Sell
20
-280
-93% -$1.48K ﹤0.01% 5684
2014
Q1
$2K Hold
300
﹤0.01% 5080
2013
Q4
$2K Sell
300
-1,248
-81% -$8.32K ﹤0.01% 4902
2013
Q3
$11K Hold
1,548
﹤0.01% 4858
2013
Q2
$14K Buy
+1,548
New +$9.95K ﹤0.01% 4546

Other funds holding NPTN

Ameriprise's NPTN Position: Q2 2022 in Review

Ameriprise sold out of NEOPHOTONICS CORP (NPTN) in Q2 2022, closing a stake of 87,464 shares — an estimated $1.33M sold.

Ameriprise first reported a position in NPTN in Q2 2013 and held it in 29 quarters. The position peaked at $9.26M in Q3 2021. 156 funds tracked by Wall St. Rank hold NPTN as of Q2 2022.

  • Ameriprise reported no remaining NEOPHOTONICS CORP position as of Q2 2022 after selling out during the quarter.
  • Ameriprise sold 87,464 NEOPHOTONICS CORP shares in Q2 2022, an estimated $1.33M.
  • Ameriprise first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 29 quarters.
  • Ameriprise's NEOPHOTONICS CORP position peaked at $9.26M in Q3 2021.
  • 156 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2022.

Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.